JP Morgan Maintains Overweight on Exponent, Lowers Price Target to $95

Benzinga Newsdesk www.benzinga.com Negative 83.4%

Neg 83.4% Neu 0% Pos 0%

JP Morgan analyst Tomohiko Sano maintains Exponent (NASDAQ:EXPO) with a Overweight and lowers the price target from $100 to $95.